Singapore–April 27, 2017 – Vishuo Biomedical participated in the Singapore Molecular Diagnostics Symposium organised by NUH Molecular Diagnosis Centre. This symposium showcases clinical and translational applications of genomic technologies in Singapore focusing on cardiology, infectious diseases, oncology, prenatal and preimplantation diagnostics with emphasis on the emergence of next generation sequencing.

This symposium was attended by many members from the research and medical community in Singapore. At this symposium, Vishuo officially launched its latest product, Origo, the latest precision oncology platform specifically tailored for analysing patient molecular profile, elucidating the mechanisms and clinical interpretation of the genetic variants and their association with targeted treatment and drug response in a routine clinical testing environment. After the product launch, Origo received a lot of positive feedback and attracted a lot of interest amongst the attendees.